$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
坦罗莫司适用于治疗什么病症?
2025-10-19 11:44:20
Check Details
坦罗莫司作用效果
2025-10-19 11:44:20
Check Details
坦西莫司进医保了吗?
2025-10-19 11:44:20
Check Details
坦西莫司价格是多少?
2025-10-19 11:44:20
Check Details
坦西莫司最新版说明书
2025-10-19 11:44:20
Check Details
坦西莫司治疗肾癌的治疗效果怎么样?
2025-10-19 11:44:20
Check Details
坦西莫司国内上市了吗?
2025-10-19 11:44:20
Check Details
坦西莫司怎么买呢?
2025-10-19 11:44:20
Check Details
坦西莫司是哪产的?
2025-10-19 11:44:20
Check Details
阿西替尼上市日期
2025-10-19 11:44:20
Check Details
阿西替尼效果好吗?
2025-10-19 11:44:20
Check Details
阿西替尼的说明书
2025-10-19 11:44:20
Check Details
1
2
...
2215
2216
2217
2218
2219
2220
2221
...
4159
4160
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Capmatinib (Tabrecta): Generational Positioning, Adverse Effect Incidence, and Comprehensive Management
2
Dabrafenib (TAFINLAR): Indications, Adverse Effect Management, and Dose Modification Guide
3
Adagrasib (Krazati): A Complete Guide to Side-Effect Recognition and Grade-Based Management
4
Tepotinib (TEPMETKO): Complete Dosing, Side-Effect Management, and Discontinuation Guide
5
Tivozanib Dosage and Administration: Standard Dosing, Cycle Schedule, and Hepatic Impairment Adjustments
6
Vemurafenib: Mechanism of Action and Clinical Role in BRAF V600E–Targeted Therapy
7
Sotorasib (Lumakras): A Comprehensive Guide to the First KRAS G12C-Targeted Inhibitor
8
Comprehensive Interpretation of Osimertinib: Efficacy, Side Effects and Medication Standards
9
Sotorasib: Can the First KRAS G12C-Targeted Therapy Cure Cancer?
10
Trametinib (Mekinist): Refrigerated Storage, Fasting Administration, and BRAF Mutation Indications Explained
11
Belzutifan (Welireg): HIF-2α Inhibitor for VHL-Associated Tumors and Renal Cell Carcinoma — Dosing Phases, Survival Data, and Efficacy Insights
12
Pemigatinib vs. Anlotinib: Key Differences Between FGFR-Targeted Therapy and Multi-Target Anti-Angiogenic Treatment